Male menopause

References

• Werner AA. The male climacteric. JAMA 1939; 112(15): 1441–3
   Google Scholar
• Heller CG, Myers GB. The male climacteric, its symptomatology, diagnosis and treatment. JAMA 1944; 126: 472–7
   Google Scholar
• Outlook for US population growth. Stat Bull Metrop In sur Co 1994; 75(4): 19–26
   Google Scholar
• Harman SM, Tsitouras PD. Reproductive hormones in aging men. 1. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin. J Clin Endocrinol Metab 1980; 51(1): 35–40
   PubMed Web of Science ®Google Scholar
• Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 1983; 56(6): 1278–81
   PubMed Web of Science ®Google Scholar
• Morley JE. Endocrine factors in geriatric sexuality. Clin Geriatr Med 1991; 7(1): 85–93
   PubMedGoogle Scholar
• Kley HK, Nieschlag E, Bidlingmaier F, et al. Possible age-dependent influence of estrogens on the binding of testosterone in plasma of adult men. Horm Metab Res 1974; 6(3): 213–6
   PubMed Web of Science ®Google Scholar
• Swerdloff RS, Wang C. Androgens and aging in men. Exp Gerontol 1993; 28(4–5): 435–46
   PubMed Web of Science ®Google Scholar
• Muta K, Kato K, Akamine Y, et al. Age-related changes in the feedback regulation of gonadotrophin secretion by sex steroids in men. Acta Endocrinol (Copenh) 1981; 96(2): 154–62
   PubMedGoogle Scholar
• Neaves WB, Johnson L, Porter JC, et al. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab 1984; 59(4): 756–63
   PubMed Web of Science ®Google Scholar
• Schwartz D, Mayaux MJ, Spira A, et al. Semen characteristics as a function of age in 833 fertile men. Fertil Steril 1983; 39(4): 530–5
   PubMed Web of Science ®Google Scholar
• Nieschlag E, Lammers U, Freischem CW, et al. Reproductive functions in young fathers and grandfathers. J Clin Endocrinol Metab 1982; 55(4): 676–81
   PubMed Web of Science ®Google Scholar
• Johnson L, Petty CS, Neaves WB. Influence of age on sperm production and testicular weights in men. J Reprod Fertil 1984; 70(1): 211–8
   PubMedGoogle Scholar
• Bishop MW. Ageing and reproduction in the male. J Reprod Fertil Suppl 1970; 12: 65–87
   PubMedGoogle Scholar
• NIH Consensus Development Conference Summary. Impotence. JAMA 1993; 270(1): 83–90
   PubMed Web of Science ®Google Scholar
• Feldman HA, Goldstein I, Hatzi- christou DG, et al. Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study. Int J Impot Res 1992; 4(Suppl 2): A17
   Google Scholar
• Sheehy G. The unspeakable passage: is there a male menopause? Vanity Fair 1993 (Apr): 163
   Google Scholar
• Schiavi RC, Rehman J. Sexuality and aging. Urol Clin North Am 1995; 22(4): 711–26
   PubMed Web of Science ®Google Scholar
• Rowland DL, Greenleaf WJ, Dorf-man LJ, et al. Aging and sexual function in men. Arch Sex Behav 1993; 22(6): 545–57
   PubMed Web of Science ®Google Scholar
• Schiavi RC, White D, Mandeli J, et al. Hormones and nocturnal penile tumescence in healthy aging men. Arch Sex Behav 1993; 22(3): 207–15
   PubMed Web of Science ®Google Scholar
• Davidson JM, Chen JJ, Crapo L, et al. Hormonal changes and sexual function in aging men. J Clin Endocrinol Metab 1983; 57(1): 71–7
   PubMed Web of Science ®Google Scholar
• Davidson JM, Camargo CA, Smith ER. Effects of androgen on sexual behavior in hypogonadal men. J Clin Endocrinol Metab 1979; 48(6): 955–8
   PubMed Web of Science ®Google Scholar
• Kaiser FE, Viosca SP, Morley JE, et al. Impotence and aging: clinical and hormonal factors. J Am Geriatr Soc 1988; 36(6): 511–9
   PubMed Web of Science ®Google Scholar
• Drinka PJ, Bauwens SF. Male osteopenia: a brief review. J Am Geriatr Soc 1987; 35(3): 258–61
   PubMed Web of Science ®Google Scholar
• Stanley HL, Schmitt BP, Poses RM, et al. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991; 39(8): 766–71
   PubMed Web of Science ®Google Scholar
• Crilly RG, Francis RM, Nordin BE. Steroid hormones, ageing and bone. Clin Endocrinol Metab 1981; 10(1): 115–39
   PubMedGoogle Scholar
• Jackson JA, Kleerekoper M, Parfitt AM, et al. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab 1987; 65(1): 53–8
   PubMed Web of Science ®Google Scholar
• Foresta C, Zanatta GP, Busnardo B, et al. Testosterone and calcitonin plasma levels in hypogonadal osteoporotic young men. J Endocrinol Invest 1985; 8(4): 377–9
   PubMed Web of Science ®Google Scholar
• Carlson KE, Alston W, Feldman DJ. Electromyographic study of aging in skeletal muscle. Am J Physical Med 1964; 43(4): 141–5
   PubMedGoogle Scholar
• Bhasin S, Storer T, Strakova J, et al. Anabolic effects of androgens: testosterone increases lean body mass, muscle size and strength in hypogonadal men. (Abstr) J Androl 1994; (Jan/Feb): P40
   Google Scholar
• Morley JE, Perry HM 3d, Kaiser FE, et al. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 1993; 41(2): 149–52
   PubMed Web of Science ®Google Scholar
• Marin P, Holmang S, Gustafsson C, et al. Androgen treatment in abdominally obese men. Obesity Res 1993; 1(4): 245–51
   PubMedGoogle Scholar
• Katznelson L, Finkelstein J, Baressi C, et al. Increase in trabecular bone density and altered body composition in androgen replaced hypogonadal men. Presented before the 76th Endocrine Society Annual Meeting, Anaheim, Calif: 1994 Jun
   Google Scholar
• Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992; 75(4): 1092–8
   PubMed Web of Science ®Google Scholar
• Osterman J. Androgen replacement therapy. In: Bardin CW. Current therapy in endocrinology and metabolism. 5th ed. St Louis: Mosby, 1994: 286–91
   Google Scholar
• Matsamuto AM. Clinical use and abuse of androgens and antiandrogens. In: Becker KL, ed. Principles and practice of endocrinology and metabolism. 2d ed. Philadelphia: Lippincott, 1995: 1110–23
   Google Scholar
• Meikle AW, Arver S, Dobs AS, et al. Androderm: A permeation enhanced non- scrotal testosterone transdermal system for the treatment of male hypogonadism. In: Bhasin S, Gabelnick HC, Spieler JM, et al, eds. Pharmacology, biology, and clinical applications of androgens. New York: Wiley-Liss, 1996: 449–57
   Google Scholar
• Matsumoto AM, Sandblom RE, Schoene RB, et al. Testosterone replacement in hypogonadal men: effects on obstructive sleep apnoea, respiratory drives, and sleep. Clin Endocrinol (Oxf) 1985; 22(6): 713–21
   PubMed Web of Science ®Google Scholar
• McNutt RA, Feren chick GS, Kirlin PC. Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol 1988; 62(1): 164
   PubMed Web of Science ®Google Scholar
• Frankle MA, Eichberg R, Zachariah SB. Anabolic androgenic steroids and a stroke in an athlete: case report. Arch Phys Med Rehabil 1988; 69(8): 632–3
   PubMed Web of Science ®Google Scholar
• Thompson PD, Cullinane EM, Sady SP, et al. Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. JAMA 1989; 261(8): 1165–8
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E. Testosterone, HDL-cholesterol and cariovascular disease in men. In: Bhasin et al, eds,” pp 215–27
   Google Scholar
• Matsumoto AM. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. J Clin Endocrinol Metab 1990; 70(1): 282–7
   PubMed Web of Science ®Google Scholar
• Ferenchick G, Schwartz D, Ball M, et al. Androgenic-anabolic steroid abuse and platelet aggregation: a pilot study in weight lifters. Am J Med Sci 1992; 303(2): 78–82
   PubMed Web of Science ®Google Scholar
• Shiraishi T, Watanabe M, Matsuura H, et al. The frequency of latent prostatic carcinoma in young males: the Japanese experience. In Vivo 1994; 8(3): 445–7
   PubMedGoogle Scholar
• Sakr WA, Grignon DJ, Crissman JD, et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: an autopsy study of 249 cases. In Vivo 1994; 8(3): 439–44
   PubMedGoogle Scholar
• Isaacs JT. Role of androgens in prostatic carcinoma. Vitam Horm 1994; 49: 433–502
   PubMed Web of Science ®Google Scholar